Increasing CRPM levels following antifibrotic therapy in IPF is associated with adverse outcomes with nintedanib, but not pirfenidone
EUROPEAN RESPIRATORY JOURNAL(2023)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
EUROPEAN RESPIRATORY JOURNAL(2023)